1,746
Views
0
CrossRef citations to date
0
Altmetric
Public Health

Trends of non-melanoma skin cancer incidence in Hong Kong and projection up to 2030 based on changing demographics

, , ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 146-154 | Received 25 Jul 2022, Accepted 28 Nov 2022, Published online: 15 Dec 2022

References

  • Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet. 2010;375(9715):673–685.
  • Leiter U, Keim U, Garbe C. Epidemiology of skin cancer: update 2019. Adv Exp Med Biol. 2020;1268:123–139.
  • Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 1994;30(5 Pt 1):774–778.
  • Brandt MG, Moore CC. Nonmelanoma skin cancer. Facial Plast Surg Clin North Am. 2019;27(1):1–13.
  • Apalla Z, Nashan D, Weller RB, et al. Skin cancer: epidemiology, disease burden, pathophysiology, diagnosis, and therapeutic approaches. Dermatol Ther. 2017;7(Suppl 1):5–19.
  • Apalla Z, Lallas A, Sotiriou E, et al. Epidemiological trends in skin cancer. Dermatol Pract Concept. 2017;7(2):1–6.
  • Wu X, Elkin EE, Marghoob AA. Burden of basal cell carcinoma in USA. Future Oncol. 2015;11(22):2967–2974.
  • Mudigonda T, Pearce DJ, Yentzer BA, et al. The economic impact of nonmelanoma skin cancer: a review. J Natl Compr Canc Netw. 2010;8(8):888–896.
  • Rogers HW, Weinstock MA, Feldman SR, et al. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. Population, 2012. JAMA Dermatol. 2015;151(10):1081–1086.
  • Gordon R. Skin cancer: an overview of epidemiology and risk factors. Semin Oncol Nurs. 2013;29(3):160–169.
  • Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166(5):1069–1080.
  • Hong Kong Cancer Registry, Hospital Authority. Overview of Hong Kong cancer statistics of 2019 [cited 2022 May 10]. Available from: https://www3.ha.org.hk/cancereg/allages.asp
  • Cheng SY, Luk NM, Chong LY. Special features of nonmelanoma skin cancer in Hong Kong Chinese patients: 10-year retrospective study. Hong Kong Med J. 2001;7:22–28.
  • United Nations, Department of Economic and Social Affairs, Population Division. World population prospects 2019. Online Edition. Rev. 1 [cited 2022 May 10]. Available from: https://population.un.org/wpp/Download/Standard/Population/
  • Rosenberg PS, Check DP, Anderson WF. A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev. 2014;23(11):2296–2302.
  • Zou Z, Cini K, Dong B, et al. Time trends in cardiovascular disease mortality across the BRICS: an age-period-cohort analysis of key nations with emerging economies using the global burden of disease study 2017. Circulation. 2020;141(10):790–799.
  • Riebler A, Held L. Projecting the future burden of cancer: Bayesian age-period-cohort analysis with integrated nested Laplace approximations. Biom J. 2017;59(3):531–549.
  • Knoll M, Furkel J, Debus J, et al. An R package for an integrated evaluation of statistical approaches to cancer incidence projection. BMC Med Res Methodol. 2020;20(1):257.
  • Roth GA, Forouzanfar MH, Moran AE, et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015;372(14):1333–1341.
  • Cheng X, Yang Y, Schwebel DC, et al. Population ageing and mortality during 1990–2017: a global decomposition analysis. PLOS Med. 2020;17(6):e1003138.
  • Cheng X, Tan L, Gao Y, et al. A new method to attribute differences in total deaths between groups to population size, age structure and age-specific mortality rate. PLOS One. 2019;14(5):e0216613.
  • Burd A, Cheung MK. Non-melanoma skin cancer in Hong Kong. Hong Kong Med J. 2001;7:322–323.
  • Demers AA, Nugent Z, Mihalcioiu C, et al. Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population. J Am Acad Dermatol. 2005;53(2):320–328.
  • Alfredsson L, Armstrong BK, Butterfield DA, et al. Insufficient sun exposure has become a real public health problem. Int J Environ Res Public Health. 2020;17(14):5014.
  • Chowdhury R, Kunutsor S, Vitezova A, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomized intervention studies. BMJ. 2014;348:g1903.
  • Mohr SB, Gorham ED, Kim J, et al. Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer. Anticancer Res. 2014;34(3):1163–1166.
  • Gorham ED, Garland CF, Garland FC, et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta-analysis. Am J Prev Med. 2007;32(3):210–216.
  • Weller RB. The health benefits of UV radiation exposure through vitamin D production or non-vitamin D pathways. Blood pressure and cardiovascular disease. Photochem Photobiol Sci. 2017;16(3):374–380.
  • Geldenhuys S, Hart PH, Endersby R, et al. Ultraviolet radiation suppresses obesity and symptoms of metabolic syndrome independently of vitamin D in mice fed a high-fat diet. Diabetes. 2014;63(11):3759–3769.
  • Munger K, Hongell K, Aivo J, et al. Serum levels of 25-hydroxyvitamin D and risk of multiple sclerosis among women in the Finnish maternity cohort. Mult Scler J. 2016;22:69–70.
  • Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296(23):2832–2838.
  • Littlejohns TJ, Henley WE, Lang IA, et al. Vitamin D and the risk of dementia and Alzheimer disease. Neurology. 2014;83(10):920–928.
  • Kocovska E, Fernell E, Billstedt E, et al. Vitamin D and autism: clinical review. Res Dev Disabil. 2012;33(5):1541–1550.
  • Cao K, Wan Y, Yusufu M, et al. Significance of outdoor time for myopia prevention: a systematic review and meta-analysis based on randomized controlled trials. Ophthalmic Res. 2020;63(2):97–105.